Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C472791 |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in decreased expression of CNTNAP2 mRNA | decreases expression | 16788091
|
D002945 |
Cisplatin |
CNTNAP2 protein affects the susceptibility to Cisplatin | affects response to substance | 16217747
|
D004041 |
Dietary Fats |
Dietary Fats results in increased expression of CNTNAP2 mRNA | increases expression | 18042831
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CNTNAP2 mRNA | affects cotreatment|increases expression | 17942748
|
C041786 |
palm oil |
palm oil results in increased expression of CNTNAP2 mRNA | increases expression | 18042831
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CNTNAP2 mRNA | affects cotreatment|increases expression | 17942748
|
C024746 |
tobacco tar |
tobacco tar results in decreased expression of CNTNAP2 mRNA | decreases expression | 19559774
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of CNTNAP2 mRNA | increases expression | 19101580
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
9.46 | 15322242 11752688 14514962 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
9.46 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.17 | 19490988 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.32 | 17505938 |
MESH:D058186 |
Acute Kidney Injury |
|
Cisplatin |
4.20 | 17670903 15814532 12690470 |
MESH:D000230 |
Adenocarcinoma |
|
Cisplatin |
4.63 | 11798837 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.63 | 14692618 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.71 | 16835633 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.61 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.17 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.76 | 17497229 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
10.95 | 15238619 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
10.95 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.80 | 15885639 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 18179894 21310003 18621663 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.99 | 18316065 18558336 17157402 18985861 17507914 19460635 17688650 18940202 18396377 15238991 16609825 18177632 18775368 19232924 20603192 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.18 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.29 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.17 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
8.50 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
8.50 | 8888407 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Cisplatin |
5.26 | 14601052 |
MESH:D001943 |
Breast Neoplasms |
|
Cisplatin |
1.91 | 19526202 18382427 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
1.91 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.91 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.99 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cisplatin |
2.44 | 17982673 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Cisplatin |
3.10 | 12023789 16685392 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Cisplatin |
2.87 | 17066447 18337622 6189445 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.49 | 18670907 18850075 16120746 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
tobacco tar |
4.10 | 19559774 |
MESH:D002659 |
Child Development Disorders, Pervasive |
marker/mechanism |
|
| 21082657 21572417 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.78 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.38 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
3.05 | 11677210 17681005 17110522 16919318 16105132 17333356 15861022 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.19 | 15340226 15668235 12621046 16354765 8697196 |
MESH:D015179 |
Colorectal Neoplasms |
|
Cisplatin |
2.33 | 15273666 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.27 | 14669216 17141729 |
OMIM:610042 |
CORTICAL DYSPLASIA-FOCAL EPILEPSY SYNDROME |
marker/mechanism |
|
| |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.53 | 15322242 10048152 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
2.53 | 8888407 17688650 16575769 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.71 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.97 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
3.97 | 1733752 19641884 |
MESH:D004362 |
Drug Toxicity |
|
Cisplatin |
8.77 | 12649298 19839026 12231392 15033597 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
8.77 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.62 | 18367378 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.31 | 1851702 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.61 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.28 | 16714409 15322242 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.47 | 12538720 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.25 | 9294722 10568697 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.46 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.29 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
marker/mechanism |
|
| 20502679 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.04 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.80 | 7562514 6426943 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.60 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.40 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
Cisplatin |
2.83 | 17638652 15464296 16785472 15173087 16481741 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.19 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
14.58 | 18296743 19004024 17967931 19551842 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
14.58 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
14.58 | 14986274 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.76 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.26 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.41 | 8888407 18558336 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
9.66 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.66 | 20067830 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.97 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Cisplatin |
3.87 | 15102660 15464296 |
MESH:D034381 |
Hearing Loss |
|
Cisplatin |
4.51 | 19898482 |
MESH:D006319 |
Hearing Loss, Sensorineural |
|
Cisplatin |
4.62 | 15464296 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.44 | 10048152 11294989 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.58 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.20 | 15340226 16120746 12621046 |
MESH:D006689 |
Hodgkin Disease |
|
Cisplatin |
3.80 | 16170182 16200630 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.20 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.42 | 18606429 16959395 16354765 8697196 15340226 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.83 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.87 | 21332399 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.98 | 18850075 18670907 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
4.12 | 16945680 16569931 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.72 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.64 | 17937319 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
5.29 | 20412841 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.29 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
3.25 | 11836018 18457598 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.58 | 16580747 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Cisplatin |
5.52 | 15464296 |
MESH:D007674 |
Kidney Diseases |
|
Cisplatin |
3.36 | 18289764 12649298 19839026 15190930 12231392 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Cisplatin |
5.17 | 11231351 |
MESH:D007805 |
Language Development Disorders |
marker/mechanism |
|
| 21082657 21310003 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.18 | 16294345 17596541 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
2.99 | 18296743 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
1.24 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
1.79 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.24 | 12151625 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.64 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Cisplatin |
2.52 | 6189445 11798837 17225452 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.52 | 19555203 11884234 |
MESH:D008545 |
Melanoma |
|
Cisplatin |
2.50 | 15577323 12393984 18505091 16432458 16248763 12374674 17761969 18176117 16809738 12883367 17023156 18332650 11135225 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Cisplatin |
5.11 | 15990972 |
MESH:D008654 |
Mesothelioma |
|
Cisplatin |
3.32 | 17638057 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.36 | 18765137 18803445 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.27 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.28 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.21 | 12213967 |
MESH:D009369 |
Neoplasms |
|
Cisplatin |
3.04 | 16773208 |
MESH:D009395 |
Nephritis, Interstitial |
|
Cisplatin |
4.87 | 15464296 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.49 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.27 | 16359493 8888407 |
MESH:D009447 |
Neuroblastoma |
|
Cisplatin |
3.56 | 8761367 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cisplatin |
5.03 | 8761367 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
2.33 | 17217161 16723640 19632207 18457598 21332399 20518802 11836018 18674790 20132043 |
MESH:D010051 |
Ovarian Neoplasms |
|
Cisplatin |
2.93 | 19769630 17225452 15464296 6897625 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cisplatin |
3.06 | 19003803 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.95 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.62 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Cisplatin |
4.59 | 15464296 |
MESH:D010997 |
Pleural Neoplasms |
|
Cisplatin |
5.72 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.84 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
10.61 | 11118676 11399792 11896295 11222880 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
10.61 | 20603192 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.65 | 15861022 16919318 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.92 | 12752131 11422049 |
MESH:D051437 |
Renal Insufficiency |
|
Cisplatin |
4.71 | 15464296 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.12 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.44 | 19155313 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Cisplatin |
4.71 | 14601052 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.09 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.89 | 11044598 11738929 1511512 15475178 3137016 17978042 14763951 16876388 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.14 | 16192470 |
MESH:D055752 |
Small Cell Lung Carcinoma |
|
Cisplatin |
5.72 | 15464296 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.32 | 16709447 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.96 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.92 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Cisplatin |
2.33 | 17522103 18396642 15958060 |
MESH:D013342 |
Stuttering |
marker/mechanism |
|
| 21108403 |
MESH:D013736 |
Testicular Neoplasms |
|
Cisplatin |
4.89 | 15464296 17225452 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.88 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.37 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.28 | 12697716 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.61 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.86 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cisplatin |
3.02 | 15464296 17225452 12973940 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.95 | 8888407 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Cisplatin |
4.43 | 16803524 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.58 | 14692618 |
MESH:D014625 |
Vaginal Neoplasms |
|
Cisplatin |
4.92 | 15577323 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.97 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.78 | 14671159 15869587 |
MESH:D014839 |
Vomiting |
|
Cisplatin |
5.09 | 11897121 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.62 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.95 | 16723640 |